​BayCare produces a bi-monthly electronic newsletter to the physician community that addresses the latest cardiovascular issues. These topics are selected by our advisory committee.
We've gathered all the issues of our newsletter into this library for your quick reference.
Transcatheter Aortic Valve Replacement (TAVR) in patients at low-risk for Surgical Aortic Valve Replacement (SAVR).
Tight glucose control with insulin prevents microvascular complications in patients with type 2 diabetes mellitus (DM), but has not been shown to prevent macrovascular complications or improve cardiovascular mortality.
The new SVS WIfI classification provides a staging system for the increasing diabetic population with PVD to guide amputation risk and need for revascularization.
Although we divide VT into two different groups (patients with and without structural heart disease), in this discussion we’ll be referring to VT in a patient with structural heart disease.
Pre-participation screening is an integral part of identifying individuals who may be at risk for cardiac problems including sudden cardiac arrest and sudden cardiac death.
the patients who undergo cardiac catheterization and can be as high as 50 percent in patients with a previous history of bypass.
Regardless of a patient’s CHD complexity, virtually all CHD-related diagnostic or interventional management should be conducted by cardiologists who are specially trained in CHD imaging, CHD catheter intervention and CHD electrophysiology.
Recent rapid technologic advances have contributed to the widespread clinical use of cardiac computed tomography (CT).
Cardiogenic shock is a life-threatening medical condition resulting from an inadequate circulation of blood due to primary failure of the ventricles of the heart to function effectively.
The STS database provides a standardized format for data collection and allows comparison of outcomes and elective public reporting for participating heart surgery programs who are willing to share their results with consumers.
Cardiac rehabilitation is a comprehensive secondary prevention program that developed as an important component of care following the hospitalization of patients with cardiovascular disease.
Treatment guidelines are evolving to encourage early referral for surgical therapy in severe mitral regurgitation.
All the exciting potential advances in the field of medicine are very dependent on the conduct of clinical trials.
Two events that further the level of cardiovascular knowledge across the BayCare clinical community, broadening the ability to positively impact the lives of our patients.
Performance and quality measures to help identify patients with atrial fibrillation as a way of promoting optimal disease management.
Important data has become available on how to more effectively use diuretics to relieve symptoms quickly and durably.
​BayCare also publishes an annual update on Cardiovascular and Surgical Outcomes.